Rossom Rebecca C, Shortreed Susan, Coleman Karen J, Beck Arne, Waitzfelder Beth E, Stewart Christine, Ahmedani Brian K, Zeber John E, Simon Greg E
HealthPartners Institute, Minneapolis, Minnesota.
Group Health Research Institute, Seattle, Washington.
Depress Anxiety. 2016 Aug;33(8):765-74. doi: 10.1002/da.22532. Epub 2016 Jun 20.
Early adherence is key to successful depression treatment, but nearly 60% of patients discontinue antidepressants within 3 months. Our study aimed to determine factors associated with poor early adherence to antidepressants in a large diverse sample of patients.
Six Mental Health Research Network healthcare systems contributed data for adults with depression and a new antidepressant start, defined by a washout period of at least 270 days, between January 1, 2010 and December 31, 2012. Pharmacy fill and self-reported race/ethnicity data were obtained from the electronic medical record. Patients had early adherence if they had a second antidepressant fill within 180 days of the first. We used logistic regression to investigate the relationship between early adherence and patient characteristics.
A total of 177,469 adult patients had 184,967 new episodes of depression with a filled antidepressant prescription. Patients refilled their antidepressants within 180 days in 71% of episodes. Race/ethnicity was a strong predictor of early adherence, with patients from racial/ethnic minorities other than Native Americans/Alaskan Natives less likely (adjusted odd ratios 0.50-0.59) to refill their antidepressants than non-Hispanic whites. Age, neighborhood education, comorbidity burden, provider type and engagement in psychotherapy were also associated with adherence. Other apparent predictors of early adherence, including neighborhood income, gender, and prior mental health hospitalizations, were no longer significant in the fully adjusted model.
Race/ethnicity was a robust predictor of early antidepressant adherence, with minority groups other than Native Americans/Alaskan Natives less likely to be adherent. Further research is needed to determine whether early nonadherence in specific minority populations is intentional, due to side effects or patient preference, or unintentional and appropriate for targeted interventions to improve adherence.
早期依从性是抑郁症治疗成功的关键,但近60%的患者在3个月内停用抗抑郁药。我们的研究旨在确定在大量不同患者样本中与抗抑郁药早期依从性差相关的因素。
六个心理健康研究网络医疗系统提供了2010年1月1日至2012年12月31日期间患有抑郁症且开始使用新抗抑郁药(定义为至少270天的洗脱期)的成年人的数据。药房配药和自我报告的种族/族裔数据来自电子病历。如果患者在首次配药后180天内有第二次抗抑郁药配药,则视为早期依从。我们使用逻辑回归来研究早期依从性与患者特征之间的关系。
共有177469名成年患者有184967次新发抑郁症并开具了抗抑郁药处方。71%的病例中患者在180天内重新配药。种族/族裔是早期依从性的有力预测因素,除美洲原住民/阿拉斯加原住民外的其他少数族裔患者比非西班牙裔白人重新配药的可能性更小(调整后的比值比为0.50 - 0.59)。年龄、社区教育程度、合并症负担、医疗服务提供者类型以及接受心理治疗也与依从性有关。其他明显的早期依从性预测因素,包括社区收入、性别和先前的心理健康住院史,在完全调整模型中不再显著。
种族/族裔是抗抑郁药早期依从性的有力预测因素,除美洲原住民/阿拉斯加原住民外的少数群体依从性较低。需要进一步研究以确定特定少数群体中的早期不依从是出于故意(由于副作用或患者偏好)、无意但适合针对性干预以提高依从性,还是其他原因。